Myostatin interacts tightly with insulin-like growth factor I (IGF-I) and enables to stimulate the expression of regulator of G-protein signaling 2, a GTPase-activating protein, which restricts the Gaq and Gas signaling pathway and thereby protects against ischemic/reperfusion injury and HF development [100]. The gene discussed is MSTN; the disease is hydrops fetalis.